Greenlighting Gamida Cell [Seeking Alpha]
Magenta Therapeutics, Inc. (MGTA)
Last magenta therapeutics, inc. earnings: 11/13 08:00 am
Check Earnings Report
Company Research
Source: Seeking Alpha
SummaryGamida Cell recently executed a secondary at $4.50 a share on the back of positive Phase 3 clinical data for its lead asset.The cell therapy biotech now trades at half its 2018 post IPO price despite a likely approval and launch of omidubicel in 2021.The stock seems undervalued on a "sum of the parts" evaluation basis. A full investment analysis follows in the paragraphs below.The sad truth about humanity... isToday, we take a look at an Israeli based biotech concern. The shares seem cheap on a "sum of the parts" evaluation. A full investment analysis and investment recommendation follows in the paragraphs below.Company Overview:Gamida Cell Ltd. (GMDANicotinamide Cell Expansion Platform:Source: Company PresentationThe goal and challenge for makers of cell therapy treatments is to expand the number of donor cells while preserving the therapeutic functionality inherent in those original donor cells. Gamida’s nicotinamide (NAM) cell expansion platform leverages the biochemical pr
Show less
Read more
Impact Snapshot
Event Time:
MGTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MGTA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MGTA alerts
High impacting Magenta Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics